[ VitalConnect raises $33M in Series C ]

VitalConnect has raised $33 million in Series C funding.

Founded in 2011, VitalConnect  develops a wearable biosensor technology that remotely monitors patients and provides diagnosis solutions for caregivers. The VitalPatch® wearable biosensor is a lightweight, wireless, adhesive patch that continuously monitors and records eight patient vital signs. The VitalConnect Platform integrates the VitalPatch biosensor with mobile and cloud-based software and analytics so patients can be monitored around the clock and across care settings.

The company will use the new financing  to further commercialize its platform.

Funding  Series C
Founded  2011
Country  USA
City  San Jose, California
Founder / CEO  Nersi Nazari
Deal Size  $33M
Investors  Baxter Ventures
 MVM Life Science Partners
Previous Investors  Perceptive Advisors